# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA666765 | B | Compound was tested for inhibition activity against factor Xa (FXa) | 1 | ALA1132209 | single protein format | Scientific Literature | ||
2. | ALA662327 | B | Inhibition of blood coagulation factor Xa was determined by AT III. | 2 | ALA1130037 | single protein format | Scientific Literature | ||
3. | ALA662328 | B | Percentage binding for human Coagulation factor X (FXa) | 1 | ALA1145122 | single protein format | Scientific Literature | ||
4. | ALA662329 | B | Binding affinity of the compoumd to human coagulation factor Xa | 28 | ALA1146806 | single protein format | Scientific Literature | ||
5. | ALA662330 | B | Compound was evaluated for inhibition of amidolytic activity for chromogenic substrate Coagulation factor X | 7 | ALA1129391 | single protein format | Scientific Literature | ||
6. | ALA662331 | B | Compound was evaluated for its 50% inhibitory concentration against Coagulation factor X | 2 | ALA1129829 | single protein format | Scientific Literature | ||
7. | ALA662332 | B | Compound was evaluated for its 50% inhibitory concentration against Coagulation factor X; Inactive at IC50 >= 50 uM | 10 | ALA1129829 | single protein format | Scientific Literature | ||
8. | ALA660640 | B | Compound was evaluated for its inhibitory activity against the Coagulation factor X | 2 | ALA1147604 | single protein format | Scientific Literature | ||
9. | ALA659600 | B | Compound was evaluated for the inhibition of Coagulation factor X | 2 | ALA1130641 | single protein format | Scientific Literature | ||
10. | ALA659601 | B | In vitro inhibitory concentration required to inhibit Coagulation factor X by 50% | 4 | ALA1129832 | single protein format | Scientific Literature | ||
11. | ALA659602 | B | Compound was tested for inhibition of human Coagulation factor X | 4 | ALA1139445 | single protein format | Scientific Literature | ||
12. | ALA659603 | B | Concentration required to inhibit Coagulation factor X was determined | 2 | ALA1134950 | single protein format | Scientific Literature | ||
13. | ALA659604 | B | Concentration required to inhibit the cleavage of the chromogenic substrate by human enzyme Coagulation factor X in vitro | 1 | ALA1133331 | single protein format | Scientific Literature | ||
14. | ALA659605 | B | In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | 19 | ALA1127638 | single protein format | Scientific Literature | ||
15. | ALA659606 | B | In vitro inhibition of human Coagulation factor X. | 12 | ALA1133331 | single protein format | Scientific Literature | ||
16. | ALA659607 | B | In vitro inhibitory activity against human coagulation factor X | 42 | ALA1147598 | single protein format | Scientific Literature | ||
17. | ALA659608 | B | In vitro inhibitory activity against coagulation factor X. | 51 | ALA1147578 | single protein format | Scientific Literature | ||
18. | ALA659609 | B | In vitro inhibitory activity against Coagulation factor X was determined | 63 | ALA1137970 | single protein format | Scientific Literature | ||
19. | ALA659610 | B | In vitro inhibitory activity against human Coagulation factor X | 10 | ALA1146768 | single protein format | Scientific Literature | ||
20. | ALA659611 | B | In vitro inhibitory activity against human enzyme Coagulation factor X | 9 | ALA1131963 | single protein format | Scientific Literature |